What is the number needed to vaccinate (NNV) to prevent one hospitalization among individuals over 50 years old, given that 200 of 1,000 unvaccinated influenza cases were hospitalized versus 60 of 1,000 vaccinated cases?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Number Needed to Vaccinate: Eight

The number needed to vaccinate (NNV) to prevent one hospitalization is 8 based on the data you've presented to the Chamber of Commerce.

Calculation Method

The NNV is calculated using the absolute risk reduction (ARR) between unvaccinated and vaccinated groups:

  • Unvaccinated hospitalization rate: 200/1,000 = 20% (0.20)
  • Vaccinated hospitalization rate: 60/1,000 = 6% (0.06)
  • Absolute Risk Reduction (ARR): 20% - 6% = 14% (0.14)
  • NNV = 1/ARR = 1/0.14 = 7.14, which rounds to 8

This means you need to vaccinate 8 people over age 50 to prevent one hospitalization from influenza.

Clinical Context and Supporting Evidence

This calculation aligns with the substantial body of evidence supporting influenza vaccination in adults over 50. The ACIP guidelines 1 specifically recommend vaccination for persons aged 50-64 years because this group has increased prevalence of high-risk conditions, with 24%-32% having one or more chronic medical conditions that place them at elevated risk for influenza-related hospitalization.

Among elderly persons living outside nursing homes, influenza vaccine is 30%-70% effective in preventing hospitalization for pneumonia and influenza 2. Recent evidence confirms vaccination's protective effect, with one study showing a 47% reduction in hospitalization risk among vaccinated individuals presenting with influenza-like illness 3.

Key Points for Your Presentation

  • The 14% absolute risk reduction (from 20% to 6% hospitalization rate) represents a clinically meaningful benefit
  • This NNV of 8 is quite favorable compared to many preventive interventions
  • The calculation assumes similar influenza attack rates in both groups and focuses specifically on the outcome of hospitalization prevention
  • This metric is particularly compelling for public health advocacy, as it translates vaccine effectiveness into concrete, understandable terms for community stakeholders

References

Research

Vaccination status as a determinant of hospitalization in influenza: Insights from emergency department data.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2026

Related Questions

What is the appropriate management for a 1-year-old infant with fever and influenza-like illness without cough?
What are the 2026 treatment guidelines for influenza A infection?
What is the recommended evaluation and management for a 52-year-old man presenting with a high fever (103.3 °F) and influenza‑like illness for one week with worsening weakness?
What is the appropriate acute management for a 63-year-old man with a two‑day history of severe cough causing incontinence, left‑upper‑apical expiratory wheezing, afebrile status, respiratory rate 18 breaths per minute, oxygen saturation 96%, heart rate 107 beats per minute, blood pressure 132/62 mmHg, previously diagnosed with influenza and prescribed an inhaler, presenting to urgent care for the first time?
What is the appropriate management for a 4.5-year-old female child presenting with fever up to 101 °F, chills, dry cough, nasal congestion, and influenza?
How should I manage a 4-month-old infant presenting with cold, cough, and fever?
In a 23-year-old woman with acute agitation, pressured speech, and hypersexuality consistent with mania, which medication should be added initially to antipsychotic therapy?
Which drugs or diseases can cause elevated liver function tests (LFTs) and alkaline phosphatase (ALP)?
When are steroids indicated for chronic obstructive pulmonary disease (COPD)?
After an anterior vitrectomy, does the implanted intraocular lens seal the posterior capsule defect?
Which comprehensive hepatitis panel should be ordered for a patient with acute hepatitis who is receiving empiric doxycycline for suspected tick‑borne rickettsial disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.